Oxford Nanopore Technologies

Oxford Nanopore Technologies is developing and commercialising a new generation of nanopore-based electronic systems for analysis of single molecules, including DNA, RNA and proteins. The handheld MinION™ device, the high-throughput/high sample number PromethION™ and GridION™ systems are designed to provide novel qualities in molecular sensing such as real-time data streaming, improved simplicity, efficiency and scalability of workflows and direct analysis of the molecule of interest. The devices may be used in scientific research, personalised medicine, crop science, security and defence and environmental applications and a number of applications, methods and tools have been published by MinION users. Products and services are priced for low total-cost-of-ownership DNA sequencing (or other analyses). Oxford Nanopore is developing or providing products and services to simplify all parts of the nanopore-based molecular analysis workflow. -For sample preparation this includes VolTRAX, a rapid, programmable, portable, disposable sample preparation device designed to convert complex samples such as blood, saliva or environmental samples directly onto a nanopore sensing device. -For analysis this includes Metrichor, a cloud based service for real time molecular analyses, vertically integrated with nanopore sensing devices. MinION is commercially available and registration has opened for the PromethION Early Access programme (PEAP). Supported by a broad patent portfolio, the Oxford Nanopore pipeline includes multiple generations of nanopore-based sensing technologies, including those based on both biological and solid-state nanopores.
Company Growth (employees)
Type
Private
HQ
Oxford, GB
Founded
2005
Size (employees)
257 (est)+2%
Oxford Nanopore Technologies was founded in 2005 and is headquartered in Oxford, GB

Key People at Oxford Nanopore Technologies

Clive G. Brown

Clive G. Brown

CTO
John Milton

John Milton

Chief Scientific Officer
Hagan Bayley

Hagan Bayley

Co - founder, Board of Directors
Alan Aubrey

Alan Aubrey

Non Executive Director
Jim McDonald

Jim McDonald

Finance Director
Peter Allen

Peter Allen

Non Executive Director

Oxford Nanopore Technologies Office Locations

Oxford Nanopore Technologies has an office in Oxford
Oxford, GB (HQ)
4 Robert Robinson Avenue

Oxford Nanopore Technologies Data and Metrics

Summary Metrics

Founding Date

2005

Total Funding

$659.9 m

Latest funding size

$125.7 m

Time since last funding

9 months

Investors

Oxford Nanopore Technologies's latest funding round in December 2016 was reported to be $125.7 m. In total, Oxford Nanopore Technologies has raised $659.9 m. Oxford Nanopore Technologies's latest valuation is reported to be $1.6 b.

Oxford Nanopore Technologies Financial Metrics

Oxford Nanopore Technologies's revenue was reported to be £746 k in FY, 2015
GBP

Revenue (FY, 2015)

746 k

Gross profit (FY, 2015)

182 k

Gross profit margin (FY, 2015), %

24%

Net income (FY, 2015)

(38.5 m)

Market valuation

1.6 b

Cash (31-Dec-2015)

52.6 m
GBPFY, 2013FY, 2014FY, 2015

Revenue

746 k

Cost of goods sold

564 k

Gross profit

182 k

Gross profit Margin, %

24%
GBPFY, 2013FY, 2014FY, 2015

Cash

28.1 m24.9 m52.6 m

Current Assets

67.5 m68.3 m106.9 m

PP&E

1.4 m2 m1.9 m

Total Assets

68.9 m70.3 m108.8 m
GBPFY, 2013FY, 2014FY, 2015

Cash From Operating Activities

(23.3 m)(33.9 m)(33.1 m)

Cash From Financing Activities

39.7 m34.9 m70.4 m

Income Taxes Paid

4.3 m4.7 m5.2 m
GBPY, 2015

Revenue/Employee

3.7 k

Financial Leverage

1.1 x
Show all financial metrics

Traffic Overview of Oxford Nanopore Technologies

Oxford Nanopore Technologies Online and Social Media Presence

Oxford Nanopore Technologies News and Updates

Med-Tech Planet: Mapping Medical Device Startups Across The Globe

Global funding to private medical device companies rose in 2016, reaching nearly $4B in 2016 across 479 deals. The United States receives a lot of attention when it comes to funding medical device startups, but private companies around the world are … Continued

Depressing Bar Chart

A data inspiration Hi there, If you are a horrible tech person and didn’t download Cards Against Silicon Valley yesterday, you are clearly not horrible enough. Sinning and winning We looked at startups working in areas traditionally considered taboo, and … Continued

$1B+ Market Map: The World’s 186 Unicorn Companies In One Infographic

There are 186 private companies around the world as of 1/18/2017 that are valued at $1B+, all tracked on our real-time unicorn tracker. Collectively, these companies are worth approximately $656B. Combined, they have raised approximately $126B. Forty-two of these private companies became … Continued

Gene Rush: Investors Of All Types Spot Opportunity In Genomics

As evidenced by the increased amounts of funding and deal activity in the last few years, investors are seeing more opportunities in the genomic space. We used CB Insights data to analyze who those investors are and where they’re placing … Continued

Genomics Sees Third Year Of $1B+ Investment And Exits Pick Up

Genomics has become a hot area thanks to the fast-growing amount of genetic data available and new techniques to analyze large datasets. As excitement in the space increases, we used CB Insights data to map out the investing trends. Deals … Continued

Oxford Nanopore Technologies Company Life and Culture

You may also be interested in